Blog

Which abdominal muscle is divided by tendinous intersections, giving the “six-pack” appearance?

Muscle cells that are cylindrical and branched, each with a single, centrally located nucleus, and that contract spontaneously are

Identify the function of the sternocleidomastoid muscle.    

A pregnant woman who is in labor has a blood pressure of 189/110 mm Hg and exhibits muscle contractions followed by jerking of her arms and legs. The nurse will prepare to administer which medication to this patient?

A nurse is admitting a client to an acute care facility for a total hip arthroplasty. The client takes hydrocortisone for Addison’s disease. Which of the following actions is the nurse’s priority?

An instructor wants to know whether using an interactive math app improves students’ problem-solving skills. A group of 12 high school students takes a standardized math test before using the app. After six weeks of daily app-based practice, the same students take a posttest with similar questions. The instructor compares pretest and posttest scores to determine if the app increased performance. Which type of test should be used for this scenario?

Diabetes Mellitus Type 2 (Study Outline) For study only—this is not medical advice or a substitute for professional care. 1. Background Definition: Chronic hyperglycemia resulting from insulin resistance and progressive β-cell dysfunction. Pathophysiology: Peripheral tissues (muscle, liver, adipose) become resistant to insulin’s effects. Pancreatic β-cells initially increase insulin output but eventually fail. Associated metabolic disturbances: ↑ hepatic glucose production, ↓ peripheral glucose uptake. Epidemiology: 90% of diabetes cases. Typically develops after age 40, but increasing prevalence in adolescents with obesity. Strongly linked to obesity, sedentary lifestyle, and family history. Risk Factors: Obesity (especially central/visceral). Family history, hypertension, dyslipidemia, polycystic ovary syndrome. Certain ethnicities: African American, Hispanic, Native American, Pacific Islander. 2. History Gradual Onset Symptoms: Polyuria, polydipsia, polyphagia. Fatigue, blurred vision. Recurrent infections (e.g., skin, vaginal, urinary). Poor wound healing, acanthosis nigricans. Often Asymptomatic: May be discovered incidentally on labs. Associated Conditions: Metabolic syndrome (obesity, hypertension, dyslipidemia, insulin resistance). DKA Rare: Hyperosmolar hyperglycemic state (HHS) more common. 3. Exam Findings General: Overweight or obese body habitus. Blood pressure often elevated. Skin: Acanthosis nigricans: hyperpigmented, velvety plaques (neck, axilla). Skin tags (acrochordons). Complications: Peripheral neuropathy (sensory loss, paresthesias). Retinopathy signs on fundoscopic exam (microaneurysms, exudates). Decreased vibratory sense or absent reflexes in feet. 4. Making the Diagnosis Diagnostic Criteria (any of the following): Fasting plasma glucose ≥126 mg/dL (×2). A1C ≥6.5%. 2-hour OGTT glucose ≥200 mg/dL after 75 g glucose load. Random glucose ≥200 mg/dL with classic symptoms. Laboratory Findings: Elevated or normal C-peptide (reflects continued endogenous insulin production). No pancreatic autoantibodies (distinguishes from Type 1 DM). Screening Recommendations: Adults ≥35 years, or earlier if overweight with additional risk factors. Repeat every 3 years if normal. Gold Standard: Biochemical confirmation of hyperglycemia (fasting glucose or A1C). Common Associated Labs: Dyslipidemia: ↑ triglycerides, ↓ HDL, ↑ LDL. Possible hepatic steatosis on imaging. 5. Management (Exam Concepts) Lifestyle Modifications: Weight loss (5–10% body weight), healthy diet, regular exercise. First-line for all patients and may normalize glucose in early disease. Pharmacologic Therapy: First-line: Oral antihyperglycemics (mechanisms emphasized on PANCE): Biguanides (e.g., metformin): ↓ hepatic glucose output, ↑ insulin sensitivity. Other classes: SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, sulfonylureas. Insulin may be required for severe hyperglycemia or β-cell exhaustion. Monitoring: A1C every 3 months until stable (

Growth Hormone Deficiency & Growth Hormone Receptor Disorders (Study Outline) For study only—this is not medical advice or a substitute for professional care. 1. Background Definition:Conditions characterized by impaired growth due to inadequate GH secretion (pituitary origin) or impaired GH action (receptor or post-receptor defects). GH Deficiency: Low GH production. GH Resistance (Receptor Disorders): Normal or elevated GH, but defective GH receptor → low IGF-1. Classic example: Laron syndrome (autosomal recessive GH receptor mutation). Pathophysiology: GH normally stimulates hepatic IGF-1 production, promoting bone growth and protein synthesis. Deficiency: ↓ GH → ↓ IGF-1 → reduced linear growth. Resistance: GH present but ineffective → very low IGF-1, elevated GH due to loss of feedback. Etiology: GH Deficiency (GHD): Congenital: pituitary aplasia, midline defects, genetic defects (PROP1, PIT1). Acquired: trauma, CNS tumors (craniopharyngioma), radiation, infections, autoimmune hypophysitis. GH Resistance: GH receptor mutations (Laron syndrome). Post-receptor signaling defects. Liver disease (impaired IGF-1 synthesis). Epidemiology: Presents in childhood with poor linear growth; can also occur in adults with pituitary disease. 2. History Children: Short stature (height

Diabetes Mellitus Type 1 (Study Outline) For study only—this is not medical advice or a substitute for professional care. 1. Background Definition: Autoimmune destruction of pancreatic β-cells → absolute insulin deficiency. Pathophysiology: T-cell–mediated autoimmune attack on islet cells (especially HLA-DR3/DR4 associations). Leads to complete loss of endogenous insulin production. Onset often in childhood or adolescence but can occur at any age (“LADA” in adults). Epidemiology: Peaks at 4–6 years and 10–14 years. ~5–10% of diabetes cases in the U.S. Increased risk with family history or other autoimmune diseases (thyroiditis, celiac disease). Key Mechanism: Autoantibodies (e.g., anti-GAD65, IA-2, insulin autoantibodies) precede hyperglycemia. 2. History Typical Symptoms (Classic Triad): Polyuria, polydipsia, polyphagia. Weight loss despite normal/increased appetite. Fatigue, blurred vision. Acute Presentation: Diabetic ketoacidosis (DKA): nausea, vomiting, abdominal pain, rapid breathing, fruity breath. Risk Factors/Associations: Family history of autoimmune disease. Viral triggers (e.g., coxsackievirus). Historical Clues: Sudden symptom onset over days to weeks. No history of obesity or metabolic syndrome features. 3. Exam Findings General: Thin or underweight body habitus. Dehydration signs: dry mucous membranes, poor skin turgor. DKA Findings: Kussmaul respirations (deep, labored breathing). Fruity (acetone) odor on breath. Hypotension, tachycardia. Altered mental status in severe cases. Associated Autoimmune Conditions: Goiter (thyroid disease), vitiligo, celiac signs. 4. Making the Diagnosis Key Laboratory Findings: Fasting plasma glucose ≥126 mg/dL on two occasions. Random glucose ≥200 mg/dL with classic symptoms. A1C ≥6.5%. Oral glucose tolerance test (OGTT): 2-hour value ≥200 mg/dL. Autoimmune Markers: Positive GAD65, IA-2, insulin autoantibodies, or ZnT8 confirm autoimmune etiology. Additional Testing: Low or undetectable C-peptide (reflects lack of insulin production). Urine ketones positive in DKA or poor control. Gold Standard: Demonstration of autoimmune β-cell destruction with positive diabetes-associated autoantibodies. Distinguishing from Type 2 DM: Younger, leaner, rapid onset, ketosis-prone, autoimmune antibodies present. 5. Management (Exam Concepts) General Principles: Lifelong exogenous insulin therapy is required. Frequent glucose monitoring (SMBG or CGM). Goal A1C: generally

Hypothyroidism (Study Outline) For study only—this is not medical advice or a substitute for professional care. 1. Background Definition:A clinical syndrome resulting from deficient production of thyroid hormones (T₄ and T₃) or impaired action at the tissue level. Pathophysiology: Primary hypothyroidism (most common): failure of the thyroid gland → ↑ TSH, ↓ free T₄. Secondary (central): pituitary dysfunction → ↓ TSH and ↓ T₄. Tertiary: hypothalamic failure (↓ TRH). Common Causes (Primary): Autoimmune (Hashimoto thyroiditis) – most common in the U.S. Iatrogenic: post-thyroidectomy, radioactive iodine, or antithyroid medications. Iodine deficiency or excess. Congenital hypothyroidism (thyroid dysgenesis, enzyme defects). Drugs: lithium, amiodarone, interferon-α, tyrosine kinase inhibitors. Epidemiology: More common in women and older adults. Hashimoto’s thyroiditis often associated with other autoimmune disorders (e.g., type 1 DM, pernicious anemia). 2. History Symptoms (Gradual Onset): Fatigue, weakness, cold intolerance. Weight gain despite decreased appetite. Constipation. Dry skin, hair loss, brittle nails. Depression, memory impairment, slowed thinking. Menstrual irregularities, infertility. Severe Forms: Myxedema: severe, long-standing hypothyroidism → nonpitting edema, facial puffiness, hoarseness, periorbital swelling. Myxedema coma: life-threatening decompensation with hypothermia, bradycardia, hypotension, and hypoventilation (precipitated by illness or sedatives). Historical Clues: Prior thyroid surgery or radioactive iodine therapy. Family history of autoimmune disease. Recent medication changes (e.g., lithium, amiodarone). 3. Exam Findings General: Fatigued appearance, weight gain, coarse dry hair, pallor. Skin: Cool, dry, thickened skin; nonpitting edema (myxedema). Cardiovascular: Bradycardia, diastolic hypertension, pericardial effusion (severe). Neurologic: Delayed relaxation of deep tendon reflexes (especially Achilles). HEENT: Puffy face, periorbital edema, enlarged or atrophic thyroid. Other: Macroglossia, hoarseness, carpal tunnel syndrome. Pediatric Findings: Growth retardation, delayed bone age, developmental delay if congenital. 4. Making the Diagnosis Initial Test (Gold Standard): Serum TSH — most sensitive screening test. Interpretation: Primary hypothyroidism: ↑ TSH, ↓ free T₄. Secondary (pituitary): ↓ or inappropriately normal TSH, ↓ free T₄. Subclinical hypothyroidism: mildly ↑ TSH with normal free T₄. Autoimmune Confirmation: Positive anti-thyroid peroxidase (anti-TPO) or anti-thyroglobulin antibodies → Hashimoto thyroiditis. Other Findings: Lipid abnormalities: hypercholesterolemia, ↑ LDL. Hyponatremia: due to decreased free water clearance. Anemia: normocytic or macrocytic. Imaging: Thyroid ultrasound: heterogenous or atrophic gland (Hashimoto). MRI of pituitary: indicated if secondary hypothyroidism suspected. 5. Management (Exam Concepts) (Conceptual overview only—no dosing or treatment directives.) General Principles: Thyroid hormone replacement (e.g., levothyroxine) is standard. Primary hypothyroidism: lifelong replacement and regular TSH monitoring. Secondary hypothyroidism: monitor free T₄, not TSH, for adjustment. Special Situations (Conceptual): Myxedema coma: medical emergency—requires ICU care and supportive management. Pregnancy: increased thyroid hormone requirement; check TSH each trimester. Exam Tip: Drug-induced hypothyroidism → lithium, amiodarone. Most sensitive test: serum TSH. Hashimoto thyroiditis: firm, irregular, painless goiter + positive anti-TPO antibodies. Monitoring: Reassess TSH every 6–8 weeks after dose adjustment. Evaluate for improvement in symptoms, energy, and metabolic parameters.   QUESTION A 45-year-old woman presents with fatigue, weight gain, and constipation. Physical exam shows dry skin, bradycardia, and delayed relaxation of deep tendon reflexes. Laboratory results reveal TSH 9.8 mIU/L (elevated) and free T₄ below normal. Which of the following additional findings is most likely? A. Elevated anti-thyroid peroxidase (anti-TPO) antibodiesB. Elevated free T₃ and suppressed TSHC. Elevated serum calcium and decreased phosphateD. Decreased LDL cholesterol